UPDATE: H.R.3253 – Sustaining Excellence in Medicaid Act of 2019

LATEST ACTION: August 6, 2019 - Became Public Law No: 116-39.

BILL TITLE: Sustaining Excellence in Medicaid Act of 2019

BILL SUMMARY:

Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019

This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill

-- makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program;

-- allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings;

-- temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services;

-- temporarily extends the Medicaid demonstration program for certified community behavioral health clinics;

-- repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and

-- increases funding available to the Medicaid Improvement Fund beginning in FY2021.

[NOTE: The contents of this legislative update are current as of 06:00 AM on August 9, 2019.]

BILL NUMBER: 116th Congress: House Bill 3253 (H.R.3253)

CHAMBER OF ORIGIN: U.S. House of Representatives

CURRENT CHAMBER: U.S. House of Representatives

For DETAILED LEGISLATIVE INFORMATION on H.R.3253, visit: https://www.congress.gov/bill/116th-congress/house-bill/3253

BILL TEXT: https://www.congress.gov/bill/116th-congress/house-bill/3253/text

ACTIONS-TO-DATE (ordered by most recent first):

08/06/2019 -- House -- Became Public Law No: 116-39.

08/06/2019 -- House -- Signed by President.

08/01/2019 -- House -- Presented to President.

07/30/2019 -- House -- Motion to reconsider laid on the table Agreed to without objection.

07/30/2019 -- House -- On motion that the House agree to the Senate amendment Agreed to without objection. (text: CR H7477-7478)

07/30/2019 -- House -- Ms. Norton asked unanimous consent to take from the Speaker's Table and agree to the Senate amendment. (consideration: CR H7477-7478)

07/25/2019 -- Senate -- Message on Senate action sent to the House.

07/25/2019 -- Senate -- Passed Senate with an amendment by Voice Vote. (consideration: CR S5114)

07/25/2019 -- Senate -- Measure laid before Senate by unanimous consent.

06/19/2019 -- Senate -- Received in the Senate, read twice.

06/18/2019 -- House -- Motion to reconsider laid on the table Agreed to without objection.

06/18/2019 -- House -- On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333). (text: CR H4706-4707)

06/18/2019 -- House -- Considered as unfinished business. (consideration: CR H4751)

06/18/2019 -- House -- At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

06/18/2019 -- House -- DEBATE - The House proceeded with forty minutes of debate on H.R. 3253.

06/18/2019 -- House -- Considered under suspension of the rules. (consideration: CR H4706-4710)

06/18/2019 -- House -- Mrs. Dingell moved to suspend the rules and pass the bill, as amended.

06/13/2019 -- House -- Referred to the House Committee on Energy and Commerce.

06/13/2019 -- House -- Introduced in House.

SPONSOR(S)*:

-- Rep. Dingell, Debbie [D-MI-12]

CO-SPONSOR(S)*:

[*Note: Sponsors and co-sponsors are current as of August 6, 2019. For the most up-to-date version of the sponsor and co-sponsor lists, visit: https://www.congress.gov/bill/116th-congress/house-bill/3253/cosponsors ]

-- Rep. Guthrie, Brett [R-KY-2]

-- Rep. Pallone, Frank, Jr. [D-NJ-6]

-- Rep. Walden, Greg [R-OR-2]

-- Rep. Eshoo, Anna G. [D-CA-18]

-- Rep. Burgess, Michael C. [R-TX-26]

-- Rep. Upton, Fred [R-MI-6]

-- Rep. Welch, Peter [D-VT-At Large]

-- Rep. Walberg, Tim [R-MI-7]

-- Rep. Kennedy, Joseph P., III [D-MA-4]

COMMITTEES: House Energy and Commerce Committee.

SUBJECTS: Administrative law and regulatory procedures, Congressional oversight, Criminal investigation, prosecution, interrogation, Department of Health and Human Services, Fraud offenses and financial crimes, Government studies and investigations, Health care costs and insurance, Health care quality, Health programs administration and funding, Home and outpatient care, Long-term, rehabilitative, and terminal care, Marriage and family status, Medicaid, Mental health, Prescription drugs, State and local finance, State and local government operations.